Clinical Trial Update: Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

View source ↗

Summary

This clinical trial update describes biomarker sample collection for Provista Diagnostics' dtectDx v2 assay in a breast cancer proof-of-concept protocol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Provista Diagnostics, Inc | Conditions: Breast Cancer | Status: UNKNOWN